Speech-Language Pathologists in Santa Maria, CA Accepting Medicare

9 Speech-Language Pathologists found. Showing 1 - 9

Nicole Marie Arguelles, CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 625 S Mcclelland, Santa Maria, CA 93454 Phone: 805-614-9535    Fax: 805-614-9390

Kylie O'keefe Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 820 W Cook St, Santa Maria, CA 93458 Phone: 805-925-8877

Mrs. Shelley Marie Krueger Rieke, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1450 Oakridge Park Rd, Santa Maria, CA 93455 Phone: 805-598-4027

Ms. Sandra Garcia-barry, M.A.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 941 E Foster Rd, Santa Maria, CA 93455 Phone: 805-937-2051

Allysa Saayman, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1207 E Main St, Santa Maria, CA 93454 Phone: 805-739-3185

Laurel Ann Mason, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2530 Professional Pkwy, Santa Maria, CA 93455 Phone: 805-928-4465    Fax: 805-928-7935

Ramneek Kaur Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1207 E Main St, Santa Maria, CA 93454 Phone: 805-739-3185

Cindy High Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1351 Dolcetto Ln, Santa Maria, CA 93458 Phone: 805-929-3552

Stephanie Mckeehan, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1207 E Main St, Santa Maria, CA 93454 Phone: 805-739-3185

News Archive

Bayer and J&J's blood thinner drug triumphs at late phase clinical trial

Drug makers Bayer AG and Johnson & Johnson's new blood clot preventing drug can provide life-saving benefits at very low doses in patients who suffer from acute coronary syndrome finds a new clinical trial.

Pertuzumab combined with trastuzumab and chemotherapy extends lives of HER2-positive breast cancer patients

Patients with HER2-positive breast cancer that has spread to other parts of their body live around 16 months longer if treated with a combination of pertuzumab, trastuzumab and chemotherapy compared to those treated with trastuzumab and chemotherapy alone, updated results from the CLEOPATRA study reveal.

NPR: Medical errors in outpatient settings may exceed those in hospitals

It's been a dozen years since the Institute of Medicine shocked the public by estimating that as many as 98,000 people were dying annually because of medical mistakes in the nation's hospitals. But results from a study published in this week's JAMA suggest that outpatient care may be just as hazardous to your health.

Thousands protest health bill at Capitol

"Chanting 'Kill the bill,' thousands of conservatives rallied at the Capitol on Thursday against the Democrats' health care overhaul plan, labeling it a government takeover of the nation's medical system," The Associated Press reports.

Read more Medical News

› Verified 1 days ago